而國外針對International Society of Sexual Medicine (ISM)的會員調查 [4],在301位受訪者中,有87%的會員曾進行陰莖復健,91%的治療會在4個月內開始,而使用的方式包括口服PDE5抑制藥物(95%),陰莖海綿體藥物注射(75%),vacuum(30%)以及intraurethral prostaglandin(10%)。而在法國的泌尿科醫學會[5],有38%的醫師會例行進行陰莖復健,49%的醫師會等病人要求再進行。一樣大多數會在3個月內進行,但比較不一樣的是陰莖海綿體藥物注射為他們的首選治療。而越年輕及進行攝護腺癌根除術越多的醫師越傾向例行進行陰莖復健。
Burnett AL, Aus G, Canby-Hagino ED, et al. Erectile function outcome reporting after clinically localized prostate cancer treatment. J Urol. 2007;178(2):597-601.
Wang R. Penile rehabilitation after radical prostatectomy: where do we stand and where are we going? J Sex Med. 2007;4(4 Pt 2):1085-97.
Montorsi F, Guazzoni G, Strambi LF, et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol. 1997;158(4):1408-10.
Teloken P et al, Post-radical prostatectomy pharmacological penile rehabilitation: practice patterns among the international society for sexual medicine practitioners. J Sex Med. 2009 Jul;6(7):2032-8. (ISM members)
Giuliano F et al, How urologists manage erectile dysfunction after radical prostatectomy: a national survey (REPAIR) by the French urological association. J Sex Med. 2008 Feb;5(2):448-57. (AFU members)